190 related articles for article (PubMed ID: 31793489)
1. Coexistence of unusual and distinctive initial manifestations of severe systemic lupus erythematosus: A child's case, presenting as adrenal insufficiency associated with autoimmune polyglandular syndrome.
Karaoglan M
Niger J Clin Pract; 2019 Dec; 22(12):1781-1784. PubMed ID: 31793489
[TBL] [Abstract][Full Text] [Related]
2. Adrenal insufficiency in systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): A systematic review.
Lee KH; Lee H; Lee CH; Kim JY; Kim JM; Kim SS; Jeong S; Hwang IS; Kim N; Kim NE; Shin S; Shin D; Song JS; Shin DH; Kim JD; Kim J; Lee YS; Kang H; Kim DH; Moon SH; Rho WS; Lee JY; Kronbichler A; Shin JI
Autoimmun Rev; 2019 Jan; 18(1):1-8. PubMed ID: 30408580
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of systemic lupus erythematosus patients with adrenal hemorrhage.
Gao L; Zhang L; Luo J; Zhang G; Shen Y; Wang Y; Li M
Clin Rheumatol; 2024 Jul; 43(7):2223-2227. PubMed ID: 38724818
[TBL] [Abstract][Full Text] [Related]
5. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
[TBL] [Abstract][Full Text] [Related]
6. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
7. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
9. Extremely hypotrophic newborn of mother with systemic lupus erythematosus and antiphospholipid syndrome.
Mockova A; Dortova E; Dort J; Nahlovsky J; Korecko V; Ulcova-Gallova Z
Lupus; 2014 Mar; 23(3):313-8. PubMed ID: 24356613
[TBL] [Abstract][Full Text] [Related]
10. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in a patient with systemic lupus erythematosus and antiphospholipid syndrome: case presentation and review of the literature.
Bouki K; Venetsanaki V; Chrysoulaki M; Pateromichelaki A; Betsi G; Daraki V; Sbyrakis N; Spanakis K; Bertsias G; Sidiropoulos PI; Xekouki P
Hormones (Athens); 2023 Sep; 22(3):521-531. PubMed ID: 37436639
[TBL] [Abstract][Full Text] [Related]
11. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.
Tincani A; Andreoli L; Chighizola C; Meroni PL
Autoimmunity; 2009 May; 42(4):257-9. PubMed ID: 19811269
[TBL] [Abstract][Full Text] [Related]
12. [Ocular manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome].
Ostanek L; Modrzejewska M; Bobrowska-Snarska D; Brzosko M
Pol Arch Med Wewn; 2007; 117 Suppl():18-23. PubMed ID: 18778014
[TBL] [Abstract][Full Text] [Related]
13. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
Merrill JT
Lupus; 2004; 13(11):869-76. PubMed ID: 15580985
[TBL] [Abstract][Full Text] [Related]
14. Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.
de Amorim LC; Maia FM; Rodrigues CE
Lupus; 2017 Apr; 26(5):529-536. PubMed ID: 28394226
[TBL] [Abstract][Full Text] [Related]
15. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
16. Adrenal involvement in the antiphospholipid syndrome.
Espinosa G; Cervera R; Font J; Asherson RA
Lupus; 2003; 12(7):569-72. PubMed ID: 12892401
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients.
Medina G; Vera-Lastra O; Barile L; Salas M; Jara LJ
Lupus; 2004; 13(1):11-6. PubMed ID: 14870912
[TBL] [Abstract][Full Text] [Related]
18. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman.
Mizuno R; Fujimoto S; Fujimoto T; Nishino T; Shiiki H; Hashimoto T; Nakamura S; Dohi K
Intern Med; 2000 Oct; 39(10):856-9. PubMed ID: 11030215
[TBL] [Abstract][Full Text] [Related]
19. Cognitive disorders and antiphospholipid antibodies.
Yelnik CM; Kozora E; Appenzeller S
Autoimmun Rev; 2016 Dec; 15(12):1193-1198. PubMed ID: 27639839
[TBL] [Abstract][Full Text] [Related]
20. Rhupus; unusual presentations.
Shovman O; Langevitz P; Shoenfeld Y
Clin Rheumatol; 2015 Dec; 34(12):2041-6. PubMed ID: 26017231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
